Trial Profile
Phase II trial of CCX168 in the patients with atypical hemolytic uremic syndrome
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2017
Price :
$35
*
At a glance
- Drugs Avacopan (Primary)
- Indications Atypical Haemolytic Uraemic Syndrome
- Focus Therapeutic Use
- 15 Jun 2017 New trial record